Done prescriber convicted in stimulant distribution conspiracy
Oct 11, 2026 edition · GC-2026-0169 · Published 2026-10-11 · Version 4 · Final
A jury convicted Done prescriber Jonathan Decker of conspiracy and six controlled-substance distribution counts. DOJ describes prescriptions without examinations and despite serious clinical warnings. The individual conviction is distinct from pending corporate charges, and the reported statutory maximum is not a sentence.
What happened
DOJ’s October 2 release reports a Western District of Michigan jury conviction of Jonathan Decker for conspiracy to distribute controlled substances and six distribution counts. The department describes his distribution of more than two million stimulant pills through the Done platform and more than $1 million in prescribing compensation. It says prescriptions were issued without patient examinations, including to people with substance-use disorders or significant psychiatric conditions. The release states that no sentencing date had been set. Its 140-year statutory maximum is potential exposure, not a prison term already imposed.
The account identifies concrete warning signs beyond prescribing volume: continued stimulant prescriptions after psychiatric concerns were communicated, pharmacy refusals, and referral bonuses for recruiting other prescribers. Those details connect clinical assessment, warning escalation and compensation incentives. DOJ identifies Decker as the eleventh convicted individual in the wider Done matter, while describing Done Global’s corporate charges as pending. The broader conspiracy’s reported 37 million pills should not be substituted for Decker’s individual two-million-pill figure. Readers should distinguish the proved individual verdict, the department’s description of the wider operation and allegations against a corporate defendant that had not yet been resolved in the cited release.
Scope and timing
- Authority status
- Final
- Applicability
- Operationally relevant
- Audience
- Health systems, Provider networks, Health-tech
- Jurisdiction
- Federal
Why it matters
The case supports review of clinician independence, appropriate examinations, clinical warning escalation and compensation incentives. Done Global’s pending charges remain distinct from individual convictions.
Recommended action
Clinical leadership, Pharmacy and Compliance should test examination records, follow-up of psychiatric or substance-use warnings, pharmacy-refusal escalation, referral compensation and prescribing-volume outliers. Treat any review of automated-renewal safeguards as a preventive recommendation, rather than a mechanism established by this release.
Case details
- agencies
- U.S. Department of Justice
- entities
- Jonathan Decker
- action Type
- Criminal resolution
- event Date
- 2026-10-02
- alleged Conduct
- Conspiracy and unlawful stimulant distribution through a telehealth prescribing platform.
- resolution
- The cited release reports a jury conviction and says no sentencing date had been set. A statutory maximum is not an imposed sentence.
Operational lessons
- Review telehealth controlled-substance prescribing, clinical independence, order-volume outliers and platform compensation controls. Do not substitute technology approval for valid prescribing authority.
Sources
- Doctor convicted of conspiring to distribute over two million stimulant pillsOfficial · DOJ · 2026-10-02 · Source review 2026-10-11
Complete edition and supplemental material
This finding in the complete approved report →Regulatory horizons, CIA trends and implementation trackers remain in the full report.
Read the entire Enforcement Briefing report →